MIT Technology Review @techreview
With a similar effort applied to antibiotic resistance, we might reorganize trial design, create new surveillance networks to detect resistant pathogens, and devise new ways to fund drug development. https://t.co/DaBtqVOqTS — PolitiTweet.org